{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:35:09Z","timestamp":1770287709228,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.dld.2016.08.107","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:39:44Z","timestamp":1471048784000},"page":"1438-1443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patients"],"prefix":"10.1016","volume":"48","author":[{"given":"C\u00e2ndida","family":"Abreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cla\u00fadia Camila","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2016.08.107_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.dld.2016.08.107_bib0170","series-title":"Guidelines on the management of latent tuberculosis, infection","year":"2015"},{"key":"10.1016\/j.dld.2016.08.107_bib0175","first-page":"10","article-title":"QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment","author":"Lee","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.dld.2016.08.107_bib0180","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection \u2013 United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recommendations and Reports"},{"key":"10.1016\/j.dld.2016.08.107_bib0185","first-page":"620","article-title":"Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy","volume":"137","author":"Beglinger","year":"2007","journal-title":"Swiss Medical Weekly"},{"key":"10.1016\/j.dld.2016.08.107_bib0190","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2016.08.107_bib0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.dld.2016.08.107_bib0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1016\/j.dld.2016.08.107_bib0205","series-title":"Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control","author":"National Collaborating Centre for Chronic C, Centre for Clinical Practice at N. National Institute for Health and Clinical Excellence: Guidance","year":"2011"},{"key":"10.1016\/j.dld.2016.08.107_bib0210","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s10067-015-3099-3","article-title":"Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom","volume":"34","author":"Nisar","year":"2015","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.dld.2016.08.107_bib0215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-gamma release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflammatory Bowel Disease"},{"key":"10.1016\/j.dld.2016.08.107_bib0220","series-title":"Joana Bettencourt Teresa de Melo Marta Gomes Olena Oliveira Portugal infe\u00e7\u00e3o VIH-Sida e tuberculose em n\u00fameros \u2013 2015","author":"Antonio Dinis","year":"2015"},{"key":"10.1016\/j.dld.2016.08.107_bib0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.15403\/jgld.2014.1121.244.bcg","article-title":"Tuberculin skin test and quantiferon in BCG vaccinated, immunosuppressed patients with moderate-to-severe inflammatory bowel disease","volume":"24","author":"Kurti","year":"2015","journal-title":"Journal of Gastrointestinal and Liver Diseases: JGLD"},{"key":"10.1016\/j.dld.2016.08.107_bib0230","first-page":"1","article-title":"The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy","author":"Mantzaris","year":"2015","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2016.08.107_bib0235","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2016.08.107_bib0240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2016.08.107_bib0245","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","article-title":"Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis","volume":"64","author":"Ponce de Leon","year":"2005","journal-title":"The Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.dld.2016.08.107_bib0250","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejcdt.2015.03.032","article-title":"Comparison of the 2-step tuberculin skin test and QuantiFERON-TB Gold in-Tube test in the screening of latent tuberculosis infection in cancer patients","volume":"64","author":"Mohammad","year":"2015","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"key":"10.1016\/j.dld.2016.08.107_bib0255","first-page":"111","article-title":"Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents","volume":"31","author":"Klein","year":"2013","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.dld.2016.08.107_bib0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.dld.2016.08.107_bib0265","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thorax.57.9.804","article-title":"A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements","volume":"57","author":"Wang","year":"2002","journal-title":"Thorax"},{"issue":"Suppl. 3","key":"10.1016\/j.dld.2016.08.107_bib0270","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/314075","article-title":"What does tuberculin reactivity after bacille Calmette\u2013Guerin vaccination tell us?","volume":"31","author":"Menzies","year":"2000","journal-title":"Clinical Infectious Disease"},{"key":"10.1016\/j.dld.2016.08.107_bib0275","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.dld.2016.08.107_bib0280","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00296-015-3246-9","article-title":"Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients","volume":"35","author":"Perez-Barbosa","year":"2015","journal-title":"Rheumatology International"},{"key":"10.1016\/j.dld.2016.08.107_bib0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2277-9175.156638","article-title":"Purified protein derivative test and its booster phenomenon in patients with rheumatoid arthritis","volume":"4","author":"Salesi","year":"2015","journal-title":"Advanced Biomedical Research"},{"key":"10.1016\/j.dld.2016.08.107_bib0290","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5588\/ijtld.13.0644","article-title":"The \u2018either test positive\u2019 strategy for latent tuberculous infection before anti-tumour necrosis factor treatment","volume":"18","author":"Jung","year":"2014","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.dld.2016.08.107_bib0295","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Shahidi","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2016.08.107_bib0300","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3899\/jrheum.081292","article-title":"Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases","volume":"36","author":"Soborg","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.dld.2016.08.107_bib0305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.crohns.2011.09.011","article-title":"Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients","volume":"6","author":"Helwig","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1016\/j.dld.2016.08.107_bib0310","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.dld.2016.08.107_bib0315","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.dld.2016.08.107_bib0320","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/j.crohns.2013.03.004","article-title":"Tuberculosis in anti-TNF-alpha treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population","volume":"7","author":"Abreu","year":"2013","journal-title":"Journal of Crohn's & Colitis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865816306831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865816306831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T04:34:48Z","timestamp":1601008488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865816306831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1590865816306831"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2016.08.107","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patients","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2016.08.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}